Reuters Market Eye - Shares in mid-sized drug makers extend a recent rally as dealers cite evidence of good buying by foreign institutional investors (FIIs).
"A weaker rupee and an increasingly diversified revenue base are attracting FIIs," said a dealer with a domestic brokerage.
Shares of Aurobindo Pharma Ltd
Wockhardt Ltd
(Reporting by Indulal PM)